Gut–brain axis: how the microbiome influences anxiety and depression
JA Foster, KAMV Neufeld - Trends in neurosciences, 2013 - cell.com
Within the first few days of life, humans are colonized by commensal intestinal microbiota.
Here, we review recent findings showing that microbiota are important in normal healthy …
Here, we review recent findings showing that microbiota are important in normal healthy …
The cognitive effects of antidepressants in major depressive disorder: a systematic review and meta-analysis of randomized clinical trials
JD Rosenblat, R Kakar… - International Journal of …, 2016 - academic.oup.com
Background: Cognitive dysfunction is often present in major depressive disorder (MDD).
Several clinical trials have noted a pro-cognitive effect of antidepressants in MDD. The …
Several clinical trials have noted a pro-cognitive effect of antidepressants in MDD. The …
Gutted! Unraveling the role of the microbiome in major depressive disorder
TFS Bastiaanssen, S Cussotto… - Harvard Review of …, 2020 - journals.lww.com
Microorganisms can be found in virtually any environment. In humans, the largest collection
of microorganisms is found in the gut ecosystem. The adult gut microbiome consists of more …
of microorganisms is found in the gut ecosystem. The adult gut microbiome consists of more …
A meta-analysis of the effects of antidepressants on cognitive functioning in depressed and non-depressed samples
CE Prado, S Watt, SF Crowe - Neuropsychology review, 2018 - Springer
A thorough understanding of the cognitive effects of antidepressant medications is essential
given their frequency of use. This meta-analysis was conducted to investigate whether …
given their frequency of use. This meta-analysis was conducted to investigate whether …
Antidepressant therapies inhibit inflammation and microglial M1-polarization
HO Kalkman, D Feuerbach - Pharmacology & therapeutics, 2016 - Elsevier
Macrophages and their counterparts in the central nervous system, the microglia, detect and
subsequently clear microbial pathogens and injured tissue. These phagocytic cells alter and …
subsequently clear microbial pathogens and injured tissue. These phagocytic cells alter and …
Antibiotics in the first year of life and subsequent neurocognitive outcomes
RF Slykerman, J Thompson, KE Waldie… - Acta …, 2017 - Wiley Online Library
Aim There may be a link between disruption to the gut microbiota in early life and later
neurocognitive outcomes. We hypothesised that antibiotic use in early life is associated with …
neurocognitive outcomes. We hypothesised that antibiotic use in early life is associated with …
Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application
MJ Millan - Pharmacology & therapeutics, 2006 - Elsevier
Major depression is a debilitating and recurrent disorder with a substantial lifetime risk and a
high social cost. Depressed patients generally display co-morbid symptoms, and depression …
high social cost. Depressed patients generally display co-morbid symptoms, and depression …
Central CRH system in depression and anxiety—evidence from clinical studies with CRH1 receptor antagonists
F Holsboer, M Ising - European journal of pharmacology, 2008 - Elsevier
Basic and clinical studies provide convincing evidence that altered stress hormone
regulation frequently observed in depression and anxiety are caused by elevated secretion …
regulation frequently observed in depression and anxiety are caused by elevated secretion …
Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression–a potential biomarker?
BACKGROUND: Exaggerated corticotropin (ACTH) and cortisol response to the combined
dexamethasone (DEX)/corticotropin releasing hormone (CRH) test, indicating impaired …
dexamethasone (DEX)/corticotropin releasing hormone (CRH) test, indicating impaired …
Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder
S Watson, P Gallagher, JC Ritchie… - The British Journal of …, 2004 - cambridge.org
BackgroundHypothalamic-pituitary-adrenal (HPA) axis function, as variously measured by
the responses to the combined dexamethasone/corticotrophin-releasing hormone …
the responses to the combined dexamethasone/corticotrophin-releasing hormone …